We confirmed the downregulation of nuclear Cyld in human HCC tissue in our patient cohort (Figure 2h,i) and the association of low nuclear expression with reduced overall survival (Figure S1e). The gene discussed is CYLD; the disease is hepatocellular carcinoma.